68 results
10-Q
2013 Q2
AGIO
Agios Pharmaceuticals Inc
5 Sep 13
Quarterly report
12:00am
of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions … or liabilities that were classified as Level 3false Fair Value Measurements
8-K
AGIO
Agios Pharmaceuticals Inc
30 Jul 13
Unregistered Sales of Equity Securities
12:00am
board of directors in one or more series; (iv) establish a classified board of directors, divided into three classes, each of whose members will serve
10-Q
fkph 67mvo9xc6maj1x
5 Sep 13
Quarterly report
12:00am
8-K
EX-99.1
dxkea765pv
16 Nov 18
Agios Presents Updated Data from Phase 1 Dose-Escalation Study ofAG-881 in Patients with IDH Mutant Positive Advanced Glioma
4:01pm
10-Q
4ydzx7d
5 Sep 13
Quarterly report
12:00am
8-K
EX-99.1
pm0 xf4lzl0agx4g
4 Sep 19
Other Events
5:05pm
8-K
EX-99.3
dfq9h
9 Dec 19
Agios EstablishesProof-of-Concept for Mitapivat inNon-transfusion-dependent Thalassemia Based on Preliminary Phase 2 Results
4:02pm
10-Q
w2wj806iwwqpj5yfqi
5 Sep 13
Quarterly report
12:00am
8-K
EX-99.1
sklsp66p2k l3fikyl
22 Nov 19
Other Events
5:01pm
10-Q
bbi3qxl5uoc6ye kdz6
5 Sep 13
Quarterly report
12:00am
8-K
EX-99.1
591o2kdw0dpufmvqac2l
29 Jan 21
Index to Consolidated Financial Statements
4:08pm